Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ISRCTN17249219) titled 'A study of a new vaccine to prevent Bundibugyo Ebola virus disease in healthy adults in Uganda' on Sept. 18.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Prevention
Primary Sponsor: University of Oxford
Condition:
Prevention of Bundibugyo virus disease (Ebola) in healthy adults in Uganda
Infections and Infestations
Intervention:
Participants undergo screening to confirm eligibility before enrolment. The study consists of three cohorts.
Participants in Cohort 1 are randomly allocated in a 4:1 ...